The Future of Cardiac Surgery in Australia a Prediction From a 15 Year Experience

Jp, Richardson

doi:10.5694/j.1326-5377.1977.tb130701.x

Cited by 3 publications

(1 citation statement)

References 8 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The other bioprotheses used were the Ionescu-Shiley, the Hancock and the MMI pericardial valves (Table). 1970-1973 _ --1974 • 1977 ...... 1978 -1984 (P values: 1970-1973compared with 1974-19771970-1973compared with 1978-19841974-1977compared with 1978-1984 wise comparison statistics to examine the outcomes of patients with each type of prosthesis, revealed no significant advantage or disadvantage in terms of survival of any valvular type, whether it was inserted in either the aortic or the mitral positions. 73 '74 '75 '76 '77 '78 '79 '80 '81 '82 '83 '84 '85 Year Of note is the fact that bioprostheses were inserted in 60% of patients who were older than 65 years of age and in 85% of the 32 Aboriginal patients who underwent valvular replacement surgery.…”

Section: Resultsmentioning

confidence: 96%

Valvular surgery in Western Australia: a 15‐year review

Nidorf

Tofler

Gibson

et al. 1988

Medical Journal of Australia

View full text Add to dashboard Cite

Between 1970 and 1984,1138 patients underwent the insertion of 1300 prosthetic heart valves in Western Australia; 56% received an aortic‐valve replacement; 34% received a mitral‐valve replacement and 10% had more than one valve replaced. Mechanical valves were used in 93% of patients before 1977, in 20% of patients between 1978 and 1982 and in 70% of patients from 1983 onwards. The 30‐day mortality was 18% before 1973 and has been below 6% since 1974. The over‐all, 15‐year actuarial survival rate was 67%; this was not affected by age, sex, race, valvular position or the type of prosthesis. Both the 30‐day mortality and 15‐year survival rates were significantly worse in patients who underwent multiple valvular replacements (13% and 54%, respectively) or reoperation (16% and 58%, respectively). The major causes of death were cardiac failure and myocardial infarction (65%); endocarditis (13%); cancer (6%); and thromboembolism and bleeding (6%). The hazard rate for reoperation was low and fairly constant in patients with mechanical valves, but increased markedly after four years in patients with tissue valves. Although our experience so far suggests that survival rates are not affected by the choice of prosthesis, this may not be so in the future, as more patients with tissue valves undergo reoperation and so become exposed to an increased risk of mortality.

show abstract

Section: Resultsmentioning

confidence: 96%